Atlas Trials

Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects

Clinical trial NCT04512170 · COMPLETED

Trial details

NCT number
NCT04512170
Sponsor
Sunshine Lake Pharma Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Idiopathic Pulmonary Fibrosis
Start date
2020-07-13
Primary completion
2021-08-23
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.